Advances in prevention and treatment of infectious complications in children and adoloscents with cancer;Fortschritte in pravention und therapie infektioser komplikationen bei Kindern und Jugendlichen mit neoplastischen Erkrankungen

Klinische Padiatrie

Volumn 210, Issue 3, 1998, Pages 106-114

  Groll, Andreas H ^a   Müller, Frank Michael C ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Cancer; Infections; Mycoses; Neutropenia; Prevention; Treatment

Indexed keywords

ACICLOVIR; AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMPHOTERICIN B; AMPHOTERICIN B LIPID COMPLEX; ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; ANTIVIRUS AGENT; CEFTAZIDIME; CLINDAMYCIN; ERYTHROMYCIN; FLUCONAZOLE; FLUCYTOSINE; GANCICLOVIR; IMIPENEM; ITRACONAZOLE; METRONIDAZOLE; TEICOPLANIN; VANCOMYCIN;

ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL INFECTION; CANDIDA; CATHETER INFECTION; CENTRAL VENOUS CATHETER; CHILDHOOD CANCER; CLOSTRIDIUM DIFFICILE; FEVER; GRANULOCYTOPENIA; HERPES SIMPLEX VIRUS; HUMAN; IMMUNE DEFICIENCY; INFECTION CONTROL; MYCOSIS; NEUTROPENIA; PATHOPHYSIOLOGY; PNEUMOCYSTIS CARINII; PROGNOSIS; VIRUS INFECTION; ADOLESCENT; CHILD; FEMALE; IMMUNOLOGY; MALE; NEOPLASM; OPPORTUNISTIC INFECTION; REVIEW; RISK FACTOR;

ADOLESCENT; CHILD; FEMALE; HUMANS; MALE; NEOPLASMS; NEUTROPENIA; OPPORTUNISTIC INFECTIONS; RISK FACTORS;

EID: 0031901294     PISSN: 03008630     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2008-1043860     Document Type: Article

References (34)

1. Aquino, V. M., A. Pappo, G. R. Buchanan et al.: The changing epidemiology of bacteremia in neutropenic children with cancer. Pediatr. Infect. Dis. J. 14 (1995) 140-143
2. Bochud, P. Y., T. Calandra, P. Francioli: Bacteremia due to Viridans Streptococci in neutropenic patients: a review. Amer. J. Med. 97 (1994) 256-264
3. Campbell, A. G. M.: Immunisation for the immunosuppressed child. Arch. Dis. Child. 63 (1988) 113-114
4. Chanock, S. J., J. B. Gorlin: Granulocyte transfusions: time for a second look. Infect. Dis. Clin. North Amer. 10 (1996) 327-343
5. Cometa, A., T. Calandra, H. Gaya et al.: Monotherapy with meropenem versus combination therapy with ceftazidime plus amikacin as empiric therapy for fever in granulocytopenic patients with cancer. Antimicrob. Agents Chemother. 40 (1996) 1108-1114
6. De Pauw, B. E., S. C. Deresinski, R. Feld et al.: Ceftazidime compared with piperacillin and tobramycin for the empiric treatment of fever in neutropenic patients with cancer - a multicenter randomized trial. Ann. Intern. Med. 120 (1994) 834-844
7. De Pauw, B. E., J. P. Donelly: Controversies in the antibacterial treatment of patients with neutropenia: a matter of comprehension or apprehension? Cancer Invest. 15 (1997) 37-46
8. EORTC International Antimicrobial Therapy Cooperative Group: Ceftazidime combined with a short or long course of amikacin for empirical therapy of gram-negative bacteremia in cancer patients with granulocytopenia. New Engl. J. Med. 317 (1987) 1692-1698
9. EORTC International Antimicrobial Therapy Cooperative Group: Empiric antifungal therapy in febrile granulocytopenic patients. Amer. J. Med. 86 (1989) 668-672
10. EORTC International Antimicrobial Therapy Cooperative Group and National Cancer Institute of Canada: Vancomycin added to empirical combination antibiotic therapy for fever in granulocytopenic cancer patients. J. Infect. Dis. 163 (1991) 951-958
11. Freifeld, A. G., T. J. Walsh, D. Marshall et al.: Monotherapy for fever and neutropenia in cancer patients: A randomised comparison of ceftazidime versus imipenem. J. Clin. Oncol. 13 (1995) 165-176
12. Freifeld, A. G., T. J. Walsh, P. A. Pizzo: Infectious complications in the pediatric cancer patient. In: Pizzo, P. A., D. G. Poplack (eds.), Principles and Practice of Pediatric Oncology. 3rd edition, J. P. Lippincott, Philadelphia, 1996: pp. 1069-1114
13. Groll, A. H., P. M. Shah, C. Mentzel et al.: Trends in the postmortem epidemiology of invasive fungal infections at a university hospital. J. Infect. 33 (1996) 23-32
14. Hiemenz, J., J. Skelton, P. A. Pizzo: Perspectives on the management of catheter-related infections in cancer patients. Pediatr. Infect. Dis. J. 5 (1986) 6-11
15. Hughes, W. T., D. Armstrong, G. P. Bodey et al.: Guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever. J. Infect. Dis. 161 (1990) 381-396
16. Jones, P. G., K. V. I. Rolston, V. Fainstein et al.: Aztreonam therapy in neutropenic patients with cancer. Amer. J. Med. 81 (1986) 243-248
17. Kelly, C. P., C. Pothoulakis, J. T. LaMont: Clostridium difficile colitis. New Engl. J. Med. 330 (1994) 257-262
18. Ljungman, P., C. Cordonnier, R. deBock et al.: Immunizations after bone marrow transplantation: results of a European survey and recommendations from the infectious disease working party of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant. 15 (1995) 455-460
19. Masur, H.: Prevention and treatment of Pneumocystis pneumonia. New Engl. J. Med. 327 (1992) 1853-1860
20. Menichetti, F., P. Martino, G. Bucaneve et al.: Effects of teicoplanin and those of vancomycin in initial antibiotic regimen for febrile, neutropenic patients with hematological malignancies. Antimicrob. Agents Chemother. 38 (1994) 2041-2046
21. Pizzo, P. A.: Management of fever in patients with cancer and treatment-induced neutropenia. New Engl. J. Med. 328 (1993) 1323-1332
22. Pizzo, P. A., J. W. Hathorn, J. Hiemenz et al.: A randomized trial comparing ceftazidime alone with combination antibiotic therapy in cancer patients with fever and neutropenia. New Engl. J. Med. 315 (1986) 552-558
23. Pizzo, P. A., K. J. Robichaud, F. A. Gill et al.: Empiric antibiotic and antifungal therapy for cancer patients with prolonged fever and granulocytopenia. Amer. J. Med. 72 (1982) 101-111
24. Pizzo, P. A., K. J. Robichaud, R. Wesley et al.: Fever in the pediatric and young adult patient with cancer: A prospective study of 1001 episodes. Medicine 61 (1982) 153-165
25. Raad, I. I., G. P. Bodey: Infectious complications of indwelling vascular catheters. Clin. Infect. Dis. 15 (1992) 197-210
26. Ramphal, R., M. Bolger, D. J. Oblon et al.: Vancomycin is not an essential component of the initial empiric treatment regimen for febrile neutropenic patients receiving ceftazidime - a randomized prospective study. Antimicrob. Agents Chemother. 36 (1992) 1062-1067
27. Roilides, E., P. A. Pizzo: Perspectives on the use of cytokines in the management of infectious complications of cancer. Clin. Infect. Dis. 17 (Suppl. 2) (1993) 385-389
28. Rubin, M., J. W. Hathorn, D. Marshall et al.: Gram-positive infections and the use of vancomycin in 550 episodes of fever and neutropenia. Ann. Intern. Med 108 (1988) 30-35
29. Sable, C. A., G. R. Donowitz: Infections in bone marrow transplant recipients. Clin. Infect. Dis. 18 (1994) 273-284
30. Sloas, M. M., P. M. Flynn, S. C. Kaste, C. C. Patrick: Typhlitis in children with cancer: a 30-year experience. Clin. Infect. Dis. 17 (1993) 484-490
31. Sommerville, E. T.: Special diets for neutropenic patients: do they make a difference? Semin. Oncol. Nursing 2 (1986) 55-58
32. Stamminger, T.: Zytomegalievirus-Infektion nach Transplantation. Klinische Problematik. Diagnostik und Therapie. Dt. Ärztebl. 94 (1997) A168-173
33. Walsh, T. J., J. W. Hiemenz, E. Anaissie: Recent progress and current problems in treatment of invasive fungal infections in neutropenic patients. Infect. Dis. Clin. North Amer. 10 (1996) 365-400
34. Warren, H. S.: Strategies for the treatment of sepsis (editorial). New Engl. J. Med. 336 (1997) 952-953